Clinical Trials Directory

Trials / Unknown

UnknownNCT04462666

Oral Huzhang Granules for Acute Gouty Arthritis

Oral Huzhang Granules for Acute Gouty Arthritis: Protocol for a Randomized, Double-blind, Multicenter Clinical Trial

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
267 (estimated)
Sponsor
Shanghai Yueyang Integrated Medicine Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

We designed this study as a double-blind, randomized, controlled clinical trial. The aim of the study is to evaluate the clinical efficacy, safety and control of recurrence rate of acute gouty arthritis

Detailed description

Gout is a recurrent chronic inflammatory disease caused by monosodium urate (MSU) crystal . Acute gouty arthritis (GA) is the most common first symptom of gout. With the progress of the disease, the frequency of acute attack increases, and joint destruction may occur. The prevalence of hyperuricemia in China was about 13.3%, and the pooled prevalence of gout was 1.1%. Repeated attacks of GA seriously affect the quality of life, resulting in huge economic costs and mental stress. Due to inadequate prevention and treatment, the target of healing gout is often not achieved. In GA, TCM has shown satisfactory therapeutic effect with less adverse effects and minimal toxicity. Huzhang granule (HZG), a Chinese herbal prescription, is a compound preparation with twelve ingredients which has been used in the clinical treatment of gout for over 30 years at the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine affiliated to Shanghai University of TCM.Therefore,this double-blind, randomized, controlled clinical trial. will provide high-quality clinical evidences for evaluating the clinical efficacy, safety and control of recurrence rate of Huzhang granule ,a representative prescription for the treatment of acute gouty arthritis , in the treatment of GA.

Conditions

Interventions

TypeNameDescription
DRUGHuzhang granuleEmpty the content of one sachet into a mug, add 50ml warm water, stir until dissolved, add another 50ml hot water. Consume and complete all 100ml liquid mixture as a single dosage.
DRUGEtoricoxibtake one capsule per day in the morning, at approximately 30 minutes after the meal.
DRUGHuzhang granule PlaceboEmpty the content of one sachet into a mug, add 50ml warm water, stir until dissolved, add another 50ml hot water. Consume and complete all 100ml liquid mixture as a single dosage.
DRUGEtoricoxib Placebotake one capsule per day in the morning, at approximately 30 minutes after the meal.

Timeline

Start date
2020-07-01
Primary completion
2023-07-31
Completion
2023-08-31
First posted
2020-07-08
Last updated
2020-07-08

Source: ClinicalTrials.gov record NCT04462666. Inclusion in this directory is not an endorsement.